[Myastenia gravis unmasked by botulinum toxin].
Martínez-Matos
J A
JA
Gascón
J
J
Calopa
M
M
Montero
J
J
D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D006257:Head; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D013256:Steroids; D014202:Tremor / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D009465:Neuromuscular Agents; D013256:Steroids; D019274:Botulinum Toxins, Type A